Quality measures | |
---|---|
Measure name | Definition |
Breast Cancer Screening | Percentage of women aged 40–69 years who had at least one mammogram in the measurement year or year prior to the measurement year. |
Colorectal Cancer Screening | Percentage of adults 50 to 80 years of age who had 1 or more of the following during the measurement year: fecal occult blood test, flexible sigmoidoscopy, double contrast barium enema or air contrast barium enema, or colonoscopy. |
Comprehensive Diabetes Care: HbA1c Testing | Percentage of patients aged 18–75 years with diabetes (type 1 and type 2) who had a hemoglobin A1c test during the measurement year. |
Comprehensive Diabetes Care: Eye Exams | Percentage of patients aged 18–75 years with diabetes (type 1 and type 2) who had a retinal or dilated eye exam by an eye care professional in the measurement year or a negative retinal exam (no evidence of retinopathy) by an eye care professional in the measurement year. |
Comprehensive Diabetes Care: Cholesterol Screening | Percentage of patients aged 18–75 years with diabetes (type 1 and type 2) who had a low-density lipoprotein cholesterol test during the measurement year. |
Comprehensive Diabetes Care: Monitoring Diabetic Nephropathy | Percentage of patients aged 18–75 years with diabetes (type 1 and type 2) who received nephropathy screening, had a nephrologist visit, or had evidence of nephropathy as documented through administrative data during the measurement year. |
Definitions taken from National Committee for Quality Assurance (NCQA). HEDIS 2009. Health plan employer data & information set. Vol. 2, Technical specifications. Washington (DC): National Committee for Quality Assurance (NCQA); 2009. Detailed lists of comorbid conditions, competing diagnoses, and other exclusion criteria are contained in the original measure documentation available from the NCQA.